Declaratory Judgment Ruling From U.S. Supreme Court Could Impact Licensing Deals, ANDAs
This article was originally published in The Pink Sheet Daily
Executive Summary
High court is mulling MedImmune's right to challenge a patent licensed from Genentech while continuing to make royalty payments.